Back to search

Article

Heteroresistant Vancomycin-Intermediate <i>S. aureus</i> (hVISA) in MRSA bacteremia: risk factors and impact on the efficacy of vancomycin therapy

2025-06-12

Abstract excerpt

Heteroresistance to vancomycin among methicillin-resistant Staphylococcus aureus (MRSA) remains a diagnostic and therapeutic problem in clinical microbiology. In this prospective cohort study of 842 adult patients with MRSA bacteremia in South Korea, we investigated the prevalence, risk factors, and clinical implications of the heteroresistant vancomycin-intermediate S. aureus (hVISA) phenotype. All stored MRSA...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
608a8d7d-e034-5ce6-b2c4-05c6df99f056
DOI
10.1101/2025.06.12.25329473
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Heteroresistant Vancomycin-Intermediate <i>S. aureus</i> (hVISA) in MRSA bacteremia: risk factors and impact on the efficacy of vancomycin therapyDOI 10.1101/2025.06.12.25329473
Comparison of the clinical features, bacterial genotypes and outcomes of patients with bacteraemia due to heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-susceptible S. aureus.Semantic proximity
Vancomycin Susceptibility Trends and Prevalence of Heterogeneous Vancomycin-Intermediate <i>Staphylococcus aureus</i> in Clinical Methicillin-Resistant <i>S. aureus</i> IsolatesSemantic proximity
<i>Staphylococcus aureus</i> with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic MethodsSemantic proximity
Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance.Semantic proximity
Vancomycin Heteroresistance and Methicillin-Resistant<i>Staphylococcus aureus</i>Semantic proximity
Global distribution of heterogeneous vancomycin-intermediate Staphylococcus aureus strains (1997-2021): a systematic review and meta-analysis.Semantic proximity
Reduced Vancomycin Susceptibility in <i>Staphylococcus aureus</i> , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical ImplicationsSemantic proximity
Clinical outcomes and molecular typing of heterogenous vancomycin-intermediate Staphylococcus aureus bacteremia in patients in intensive care units.Semantic proximity
Detection of Staphylococcus aureus Isolates with Heterogeneous Intermediate-Level Resistance to Vancomycin in the United StatesSemantic proximity
Heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) emerged before the clinical introduction of vancomycin in Japan: a retrospective studySemantic proximity
Prevalence and Clinical Impact of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolated From Hospitalized Patients.Semantic proximity
Reduced Vancomycin Susceptibility Found in Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Clinical Isolates in Northeast ChinaSemantic proximity
Select a neighboring publication to make it the new centre.